Intellectual Property
Apr. 28, 2015
Hedge fund strategy raises patent office questions
Three years after Congress overhauled the system for reviewing patents for validity through the U.S. Patent and Trademark Office, federal lawmakers and patent experts are discussing whether to shut the door on some challenges.
Daily Journal Staff Writer
Three years after Congress overhauled the system for reviewing patent validity through
the U.S. Patent and Trademark Office, federal lawmakers and patent experts are discussing
whether to shut the door on some challenges.
At the heart of the discussion is an entity known as the Coalition for Affordable
Drugs LLC. Last ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In